Search Results - "Morita, Yukari"

Refine Results
  1. 1
  2. 2

    Disease progression and phenotypes of non‐motor symptoms in Parkinson’s disease by Osaki, Yasushi, Morita, Yukari, Miyamoto, Yuka, Furushima, Tomomi, Furuta, Konosuke, Furuya, Hirokazu

    Published in Neurology and clinical neuroscience (01-01-2021)
    “…Background Motor symptoms, non‐motor symptoms, and treatment‐related motor complications appear during the course of Parkinson's disease. Aim To observe the…”
    Get full text
    Journal Article
  3. 3

    Freezing of gait is an early clinical feature of progressive supranuclear palsy by Osaki, Yasushi, Morita, Yukari, Miyamoto, Yuka, Furuta, Kounosuke, Furuya, Hirokazu

    Published in Neurology and clinical neuroscience (01-05-2017)
    “…Background and Aim Early clinical diagnosis of progressive supranuclear palsy (PSP) remains challenging. Aim We attempted to identify any sign or symptom to…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Transient thyrotoxicosis‐aggravated attacks of paralysis in a patient with hereditary hypokalemic periodic paralysis type 2 by Nagamatsu, Shu‐ichi, Osaki, Yasushi, Morita, Yukari, Miyamoto, Yuka, Mori, Itsuki, Kubota, Tomoya, Takahashi, Masanori P., Furushima, Tomomi, Furuya, Hirokazu

    Published in Neurology and clinical neuroscience (01-11-2019)
    “…We report a case with hereditary hypokalemic paralysis type 2 in whom thyrotoxicosis aggravated his attacks of paralysis. He experienced paralytic attacks…”
    Get full text
    Journal Article
  6. 6

    Cross-sectional and longitudinal studies of three-dimensional stereotactic surface projection SPECT analysis in Parkinson's disease by Osaki, Yasushi, Morita, Yukari, Fukumoto, Mitsutaka, Akagi, Naoki, Yoshida, Shoji, Doi, Yoshinori

    Published in Movement disorders (30-07-2009)
    “…Although dementia is increasingly recognized as a common feature in Parkinson's disease (PD), its pathological substrate remains unknown. We conducted…”
    Get full text
    Journal Article
  7. 7

    Immediate Effects of Sit up Practice for Parkinson’s Disease Patients: Effect of Intervention with Step by Step Difficulty Adjustment on Motion Time by NAKAYAMA, Tomoharu, YAMASAKI, Hiroshi, MORITA, Yukari, OSAKI, Yasushi, FURUYA, Hirokazu

    Published in Rigaku ryoho kagaku (2022)
    “…[Purpose] This study was conducted to examine the immediate effect of sit-up practice designed with step by step difficulty adjustment on Parkinson’s disease…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Factors associated with falling in patients with Parkinson's disease and atypical parkinsonism: An assessment using the Tinetti Gait and Balance Scale by Morita, Yukari, Osaki, Yasushi, Doi, Yoshinori

    Published in Geriatrics & gerontology international (01-12-2006)
    “…Aim:  To identify factors associated with falling, we assessed the Tinetti Gait and Balance Scale (TGBS) for patients with Parkinson’s disease (PD) and…”
    Get full text
    Journal Article
  10. 10

    Identification of a Novel Alternative Splicing of Human FGF Receptor 4: Soluble-Form Splice Variant Expressed in Human Gastrointestinal Epithelial Cells by Takaishi, Shigeo, Sawada, Mitsutaka, Morita, Yukari, Seno, Hiroshi, Fukuzawa, Hiroaki, Chiba, Tsutomu

    “…Among four closely related members of the FGF receptor family, FGFR 1, 2, and 3 have alternative splicing forms encoded by different exons for the C-terminal…”
    Get full text
    Journal Article
  11. 11

    Identification of GM-CSF in Paneth cells using single-cell RT-PCR by Fukuzawa, Hiroaki, Sawada, Mitsutaka, Kayahara, Takahisa, Morita-Fujisawa, Yukari, Suzuki, Katsumasa, Seno, Hiroshi, Takaishi, Shigeo, Chiba, Tsutomu

    “…Paneth cells, granule-containing cells located at the bottom of the intestinal crypts, have a role in innate mucosal immunity. We identified the exclusive…”
    Get full text
    Journal Article
  12. 12
  13. 13

    Identification of a pre‐possible multiple system atrophy phase by Osaki, Yasushi, Morita, Yukari, Miyamoto, Yuka, Ohtsuru, Sho, Shogase, Tomohiro, Furushima, Tomomi, Furuya, Hirokazu

    Published in Acta neurologica Scandinavica (01-03-2021)
    “…Objectives A pre‐possible multiple system atrophy (MSA) phase, that is, the period between symptom onset and satisfying the second consensus diagnostic…”
    Get full text
    Journal Article
  14. 14
  15. 15
  16. 16

    Effective efgartigimod treatment for severe thymoma‐associated myasthenia gravis experiencing myasthenic crisis: A case report by Morita, Yukari, Osaki, Yasushi, Shogase, Tomohiro, Yoshimoto, Daiji, Terada, Tomomi, Ohtsuru, Sho, Yamasaki, Kako, Hashimoto, Yu, Matsushita, Takuya

    Published in Neurology and clinical neuroscience (01-09-2024)
    “…We report the long‐term treatment of a 38‐year‐old man with generalized thymoma‐associated myasthenia gravis who was treated with efgartigimod. He received…”
    Get full text
    Journal Article
  17. 17
  18. 18
  19. 19

    Quantification of human lithostathine S2-5 forms using the antibody to the N-Terminal peptide region by YAMADERA, K, WADA, K, GOTO, M, YOKOYAMA, K, MORITA, Y, KITANO, Y, MAKINO, I

    Published in Pancreas (01-05-1998)
    “…Lithostathine S2-5 inhibits in vitro crystal growth of CaCO3. We developed an antibody against the peptide region responsible for inhibitory effect to…”
    Get full text
    Journal Article
  20. 20